BioDelivery Sciences International, Inc. – NASDAQ:BDSI

Add to watchlist

$5.59

Market closed

Open in about 2 hours

+0.36%

month

+82.68%

quarter

+61.09%

year

Market Cap	577.05M
Enterprise value	442.03M

P/E	6.81
EV/Sales	5.25
EV/EBITDA	16.08
Price/Sales	6.55
Price/Book	2.93
PEG ratio	0.03
EPS	0.85

Revenue	166.70M
EBITDA	44.54M
Income	84.86M
Revenue Q/Q	2.34%
Revenue Y/Y	6.54%

Profit margin	100.82%
Oper. margin	44.11%
Gross margin	72.23%
EBIT margin	44.11%
EBITDA margin	26.72%

Get more financial ratios!

Every financial ratio you might need
10 years history
Forward ratios (Analysts estimates)

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

BioDelivery Sciences International, Inc. (NASDAQ:BDSI): Profit margin
Mar 2021	41.02M	5.23M	12.77%
Jun 2021	41.43M	9.06M	21.87%
Sep 2021	41.09M	6.66M	16.23%
Dec 2021	43.15M	63.89M	148.05%

BioDelivery Sciences International, Inc. (NASDAQ:BDSI): Earnings per share (EPS)
2021-08-04	0.05	0.09
2021-11-03	0.06	0.07
2022-03-09	0.02	0.62

BioDelivery Sciences International, Inc. (NASDAQ:BDSI): Debt to assets
Mar 2021	242130000	133.27M	55.04%
Jun 2021	250327000	136.40M	54.49%
Sep 2021	256070000	133.29M	52.05%
Dec 2021	324596000	136.77M	42.14%

BioDelivery Sciences International, Inc. (NASDAQ:BDSI): Cash Flow
Mar 2021	11.09M	-296K	-5.94M
Jun 2021	9.23M	-119K	-5.69M
Sep 2021	6.96M	-6.45M	-19.64M
Dec 2021	13.74M	-1K	-148K

BioDelivery Sciences International alternative data

Social Media

🎓 Academy: How impactful can social media data be in investment decisions

BioDelivery Sciences International
Employees

BioDelivery Sciences International, Inc. (NASDAQ:BDSI): Employee count
Aug 2023	200
Sep 2023	200
Oct 2023	200
Nov 2023	200
Dec 2023	200
Jan 2024	200
Feb 2024	200
Mar 2024	200
Apr 2024	200
May 2024	200
Jun 2024	200
Jul 2024	200

BioDelivery Sciences International
Insider Trading

BioDelivery Sciences International, Inc. (NASDAQ:BDSI): Insider trades (number of shares)
Period	Buy	Sel
May 2021	315500	0
Nov 2021	483800	10000
Dec 2021	18587	0
Feb 2022	0	18541

Transaction	Date	Insider	Security	Shares	Price per share	Total value
Option	9 Mar 2022	BAILEY JEFFREY ALLEN director, officer..	Restricted Stock Units	5,333	N/A	N/A
Option	9 Mar 2022	BAILEY JEFFREY ALLEN director, officer..	Common Stock	5,333	N/A	N/A
Sale	4 Feb 2022	VOLLINS JAMES officer: General ..	Common Stock	18,541	$3.6	$66,748
Option	31 Jan 2022	PLESHA SCOTT M. officer: Presiden..	Restricted Stock Units	45,253	N/A	N/A
Option	31 Jan 2022	PLESHA SCOTT M. officer: Presiden..	Common Stock	24,203	N/A	N/A
Option	31 Jan 2022	VOLLINS JAMES officer: General ..	Restricted Stock Units	28,413	N/A	N/A
Option	31 Jan 2022	VOLLINS JAMES officer: General ..	Common Stock	12,137	N/A	N/A
Option	31 Jan 2022	SMITH THOMAS B officer: Chief Medical Officer officer: Chief Medical Officer	Restricted Stock Units	32,576	N/A	N/A
Option	31 Jan 2022	SMITH THOMAS B officer: Chief Medical Officer officer: Chief Medical Officer	Common Stock	15,215	N/A	N/A
Option	27 Jan 2022	PLESHA SCOTT M. officer: Presiden..	Common Stock	21,050	N/A	N/A

BDSI insider trading transactions

BioDelivery Sciences International
Patents

Status	Patent	Filling date	Issue date
Application	Application MULTIDIRECTIONAL MUCOSAL DELIVERY DEVICES AND METHODS OF USE Filling date: 7 Feb 2022 Issue date: 21 Jul 2022	7 Feb 2022	21 Jul 2022
Application	Application METHODS OF TREATING PAIN Filling date: 27 Dec 2021 Issue date: 30 Jun 2022	27 Dec 2021	30 Jun 2022
Application	Application PATCH DEVICES, METHODS AND APPARATUS FOR FORMING, AND TESTING PHARMACEUTICAL AGENT DELIVERY PATCH DEVICES Filling date: 25 Dec 2021 Issue date: 16 Jun 2022	25 Dec 2021	16 Jun 2022
Application	Application SUSTAINED RELEASE BUPRENORPHINE MICROSPHERES (SRBM) AND METHODS OF USE THEREOF Filling date: 15 Sep 2021 Issue date: 10 Mar 2022	15 Sep 2021	10 Mar 2022
Application	Application ABUSE-RESISTANT MUCOADHESIVE DEVICES FOR DELIVERY OF BUPRENORPHINE Filling date: 10 Oct 2020 Issue date: 20 Jan 2022	10 Oct 2020	20 Jan 2022
Application	Application TRANSMUCOSAL DELIVERY DEVICE WITH ENHANCED UPTAKE Filling date: 22 Mar 2021 Issue date: 9 Sep 2021	22 Mar 2021	9 Sep 2021
Application	Application METHODS OF TREATMENT WITH BUPRENORPHINE Filling date: 12 Feb 2021 Issue date: 19 Aug 2021	12 Feb 2021	19 Aug 2021
Application	Application METHODS OF SAFELY TRANSITIONING A SUBJECT TO BUPRENORPHINE Filling date: 30 Jan 2021 Issue date: 22 Jul 2021	30 Jan 2021	22 Jul 2021
Application	Application ABUSE RESISTANT TRANSMUCOSAL DRUG DELIVERY DEVICE Filling date: 16 Jul 2020 Issue date: 7 Jan 2021	16 Jul 2020	7 Jan 2021
Application	Application MULTIDIRECTIONAL MUCOSAL DELIVERY DEVICES AND METHODS OF USE Filling date: 30 Apr 2020 Issue date: 19 Nov 2020	30 Apr 2020	19 Nov 2020

BDSI patents

BioDelivery Sciences International
Earnings Call Transcripts

Quarter	Transcript
Q3 2021 3 Nov 2021	Q3 2021 Earnings Call Transcript
Q2 2021 4 Aug 2021	Q2 2021 Earnings Call Transcript
Q4 2020 10 Mar 2021	Q4 2020 Earnings Call Transcript
Q2 2020 5 Aug 2020	Q2 2020 Earnings Call Transcript

BDSI earnings call transcripts

BioDelivery Sciences International
Executives

Insider	Age	Compensation
Mr. Scott M. Plesha (1965) Pres & Chief Commercial Officer	60	$629,460
Mr. Jeffrey Allen Bailey (1963) Chief Executive Officer & Director	62	$599,960
Mr. James Vollins J.D. (1969) Gen. Counsel, Chief Compliance Officer & Corporation Sec.	56	$586,680
Dr. Thomas B. Smith FAAFP, M.D. (1961) Chief Medical Officer	64	$570,060

BioDelivery Sciences International
Latest News

Friday, 18 March 2022
11:17	Has BioDelivery Sciences International (BDSI) Outpaced Other Medical Stocks This Year?	Zacks Investment Research
Wednesday, 2 March 2022
16:04	Earnings Preview: BioDelivery Sciences International (BDSI) Q4 Earnings Expected to Decline	Zacks Investment Research
Thursday, 24 February 2022
11:35	BioDelivery Sciences International (BDSI) Just Flashed Golden Cross Signal: Do You Buy?	Zacks Investment Research
Tuesday, 15 February 2022
12:20	BioDelivery (BDSI) Stock Surges on Buyout Offer From Collegium	Zacks Investment Research
Monday, 14 February 2022
14:56	BDSI Stock Alert: The Deal Sending Little-Known BioDelivery Skyrocketing Today	InvestorPlace
11:22	3 Potential Value Opportunities to Consider	GuruFocus
09:10	Trading Penny Stocks? Top Stock Market News for February 14th, 2022	PennyStocks
07:00	BioDelivery's stock rockets toward a 2-year high after buyout deal with Collegium at a 54% premium	Market Watch
Monday, 7 February 2022
13:53	Why the Earnings Surprise Streak Could Continue for BioDelivery (BDSI)	Zacks Investment Research
Monday, 24 January 2022
16:55	Why Shares of BioDelivery Sciences International Jumped 12.2% on Monday	The Motley Fool
13:26	Best Penny Stocks to Buy During The Down Market? 3 to Watch	PennyStocks
Friday, 21 January 2022
14:30	These 3 Penny Stocks Exploded Today, Here's Why	PennyStocks
12:20	BioDelivery (BDSI) Stock Up on Raised Guidance for 2021	Zacks Investment Research
Monday, 20 December 2021
22:25	BioDelivery Sciences Stock (BDSI): Why The Price Surged Today	Pulse2
17:25	Why BioDelivery Sciences International Stock Was Up 28.5% Monday	The Motley Fool
16:35	Making a List of Penny Stocks to Buy? Check These 3 Out Right Now	PennyStocks
14:39	Hot Penny Stocks To Buy For Under $5 Right Now	PennyStocks
Friday, 3 December 2021
13:00	Why Is BioDelivery (BDSI) Down 20.8% Since Last Earnings Report?	Zacks Investment Research
Wednesday, 10 November 2021
13:30	Best Reddit Penny Stocks to Buy Now? 4 to Watch in Mid-November	PennyStocks
Wednesday, 3 November 2021
12:37	BioDelivery Sciences International's (BDSI) CEO Jeff Bailey on Q3 2021 Results -Earnings Call Transcript	Seeking Alpha
10:43	BioDelivery Sciences International (BDSI) Tops Q3 Earnings Estimates	Zacks Investment Research
Tuesday, 21 September 2021
13:08	BioDelivery Sciences International (BDSI) is a Top-Ranked Momentum Stock: Should You Buy?	Zacks Investment Research
Tuesday, 14 September 2021
12:21	4 Penny Stocks To Buy According To Analysts & Price Targets Up To 507%	PennyStocks
Sunday, 12 September 2021
15:15	Best Reddit Penny Stocks To Buy Now? 5 For Your List In September 2021	PennyStocks
Thursday, 9 September 2021
10:02	BioDelivery Sciences: Legal Fees Are Causing My Pain	Seeking Alpha
Tuesday, 7 September 2021
09:28	BioDelivery Sciences to Exhibit Three Scientific Posters Comparing BELBUCA® to Oxycodone at the PAINWeek 2021 Conference	GlobeNewsWire
Friday, 3 September 2021
08:00	BioDelivery Sciences to Participate in Upcoming Virtual Investor Conferences	GlobeNewsWire
Friday, 27 August 2021
16:36	BioDelivery Sciences: Yet Another Buying Opportunity	Seeking Alpha
Friday, 20 August 2021
13:00	Top Penny Stocks You Need to Know About Right Now	PennyStocks

Ideas & Opinions

Seeking Alpha 20 Feb 2022

Collegium Pharmaceutical: Thoughts After Another Strategic Move
Seeking Alpha 9 Sep 2021

BioDelivery Sciences: Legal Fees Are Causing My Pain
Seeking Alpha 27 Aug 2021

BioDelivery Sciences: Yet Another Buying Opportunity
Seeking Alpha 28 May 2021

BioDelivery Sciences: Clinic-To-Market Transition Problem

Frequently Asked Questions (FAQ)

What's the price of BioDelivery Sciences International stock today?

One share of BioDelivery Sciences International stock can currently be purchased for approximately $5.59.
When is BioDelivery Sciences International's next earnings date?

Unfortunately, BioDelivery Sciences International's (BDSI) next earnings date is currently unknown.
Does BioDelivery Sciences International pay dividends?

No, BioDelivery Sciences International does not pay dividends.
How much money does BioDelivery Sciences International make?

BioDelivery Sciences International has a market capitalization of 577.05M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 6.54% to 166.7M US dollars. BioDelivery Sciences International earned 84.86M US dollars in net income (profit) last year or $0.62 on an earnings per share basis.
What is BioDelivery Sciences International's stock symbol?

BioDelivery Sciences International, Inc. is traded on the NASDAQ under the ticker symbol "BDSI".
What is BioDelivery Sciences International's primary industry?

Company operates in the Healthcare sector and Drug Manufacturers - Specialty & Generic industry.
How do i buy shares of BioDelivery Sciences International?

Shares of BioDelivery Sciences International can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Who are BioDelivery Sciences International's key executives?
BioDelivery Sciences International's management team includes the following people:
- Mr. Scott M. Plesha Pres & Chief Commercial Officer(age: 60, pay: $629,460)
- Mr. Jeffrey Allen Bailey Chief Executive Officer & Director(age: 62, pay: $599,960)
- Mr. James Vollins J.D. Gen. Counsel, Chief Compliance Officer & Corporation Sec.(age: 56, pay: $586,680)
- Dr. Thomas B. Smith FAAFP, M.D. Chief Medical Officer(age: 64, pay: $570,060)
How many employees does BioDelivery Sciences International have?

As Jul 2024, BioDelivery Sciences International employs 200 workers.
When BioDelivery Sciences International went public?

BioDelivery Sciences International, Inc. is publicly traded company for more then 23 years since IPO on 25 Jul 2002.
What is BioDelivery Sciences International's official website?

The official website for BioDelivery Sciences International is bdsi.com.
Where are BioDelivery Sciences International's headquarters?

BioDelivery Sciences International is headquartered at 4131 Parklake Ave Ste 225, Raleigh, NORTH CAROLINA.
How can i contact BioDelivery Sciences International?

BioDelivery Sciences International's mailing address is 4131 Parklake Ave Ste 225, Raleigh, NORTH CAROLINA and company can be reached via phone at +1 919 582 9050.

BioDelivery Sciences International, Inc.

bdsi.com

Exchange:

NASDAQ

Full time employees:

200

Industry:

Drug Manufacturers - Specialty & Generic

Sector:

Healthcare

BioDelivery Sciences International, Inc., a specialty pharmaceutical company, engages in the development and commercialization of pharmaceutical products for chronic conditions in the United States and internationally. The company provides its products based on its patented BioErodible MucoAdhesive drug-delivery technology, a small erodible polymer film for application to the buccal mucosa, as well as other drug delivery technologies. It offers BELBUCA, a buprenorphine buccal film for the treatment of chronic pain; and Symproic, a peripherally acting mu-opioid receptor antagonist for the treatment of opioid-induced constipation in adult patients with chronic non-cancer pain, including patients with chronic pain related to prior cancer or its treatment who do not require frequent opioid dosage escalation. The company also provides ELYXYB, a celecoxib oral solution for the treatment of migraine with or without aura in adults; and ONSOLIS, a fentanyl buccal soluble film for the management of breakthrough pain in cancer patients. BioDelivery Sciences International, Inc. was incorporated in 1997 and is headquartered in Raleigh, North Carolina. As of March 18, 2022, BioDelivery Sciences International, Inc. operates as a subsidiary of Collegium Pharmaceutical, Inc.

+1 919 582 9050

4131 Parklake Ave Ste 225
Raleigh, NORTH CAROLINA 27612

CIK: 0001103021
ISIN: US09060J1060
CUSIP: 09060J106